176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.86%
Positive revenue growth while Technology median is negative. Peter Lynch might see a relative strength advantage in a tough sector.
21.26%
Positive gross profit growth while Technology median is negative. Peter Lynch would see a notable competitive edge in cost or pricing.
70.38%
Positive EBIT growth while Technology median is negative. Peter Lynch might see a strong competitive advantage in operations.
70.38%
Positive operating income growth while Technology is negative. Peter Lynch would spot a big relative advantage here.
44.48%
Positive net income growth while Technology median is negative. Peter Lynch would view this as a notable competitive advantage.
45.61%
Positive EPS growth while Technology median is negative. Peter Lynch might see a strong advantage in per-share earnings compared to peers.
43.86%
Positive diluted EPS growth while Technology median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
0.24%
Share growth above Technology median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.52%
Diluted share change of 0.52% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
0.78%
Dividend growth of 0.78% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
29.44%
OCF growth of 29.44% while Technology is zero. Walter Schloss might see a modest positive difference, which can compound over time.
53.05%
FCF growth of 53.05% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.
652.53%
10Y revenue/share CAGR exceeding 1.5x Technology median of 32.98%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
120.08%
5Y revenue/share growth exceeding 1.5x Technology median of 21.88%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
132.18%
3Y revenue/share growth exceeding 1.5x Technology median of 16.61%. Joel Greenblatt might see a short-term competitive advantage at play.
1555.59%
OCF/share CAGR of 1555.59% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
97.70%
OCF/share CAGR of 97.70% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
218.43%
3Y OCF/share growth of 218.43% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
2520.23%
Net income/share CAGR exceeding 1.5x Technology median of 43.81% over a decade. Joel Greenblatt might see a standout compounder of earnings.
61.17%
5Y net income/share CAGR > 1.5x Technology median of 37.04%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
121.53%
3Y net income/share CAGR > 1.5x Technology median of 14.33%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
407.76%
Equity/share CAGR exceeding 1.5x Technology median of 40.21% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
211.82%
5Y equity/share CAGR > 1.5x Technology median of 25.49%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
86.13%
3Y equity/share CAGR > 1.5x Technology median of 12.56%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
113.76%
Dividend/share CAGR of 113.76% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
6.77%
5Y dividend/share CAGR of 6.77% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
0.45%
3Y dividend/share CAGR of 0.45% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
6.61%
Slight AR growth while Technology cuts AR. Peter Lynch wonders if the firm is missing an opportunity to collect faster or if peers face sales declines.
-10.62%
Decreasing inventory while Technology is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
7.96%
We expand assets while Technology is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
10.68%
BV/share growth of 10.68% while Technology is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
1.90%
Slightly rising debt while Technology median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
-3.94%
R&D dropping while Technology median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
1.28%
Our SG&A slightly up while Technology is cutting. Peter Lynch wonders if we overspend or if the median underinvests in marketing.